Published in Aliment Pharmacol Ther on May 15, 2007
Small-bowel capsule endoscopy: a ten-point contemporary review. World J Gastroenterol (2013) 1.66
Small bowel capsule endoscopy in 2007: indications, risks and limitations. World J Gastroenterol (2007) 1.44
Prevention and management of non-steroidal anti-inflammatory drugs-induced small intestinal injury. World J Gastroenterol (2011) 1.33
Low-dose aspirin-induced gastrointestinal diseases: past, present, and future. J Gastroenterol (2008) 1.04
Clinical use and pharmacological properties of selective COX-2 inhibitors. Eur J Clin Pharmacol (2007) 1.03
Capsule endoscopy in non-steroidal anti-inflammatory drugs-enteropathy and miscellaneous, rare intestinal diseases. World J Gastroenterol (2008) 1.01
Efficacy of Lactobacillus casei treatment on small bowel injury in chronic low-dose aspirin users: a pilot randomized controlled study. J Gastroenterol (2011) 1.00
Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage. Arthritis Res Ther (2013) 1.00
Nonsteroidal anti-inflammatory drug-induced small-bowel lesions identified by double-balloon endoscopy: endoscopic features of the lesions and endoscopic treatments for diaphragm disease. J Gastroenterol (2009) 1.00
A review of the gastrointestinal safety data--a gastroenterologist's perspective. Rheumatology (Oxford) (2010) 0.99
Rebamipide has the potential to reduce the intensity of NSAID-induced small intestinal injury: a double-blind, randomized, controlled trial evaluated by capsule endoscopy. J Gastroenterol (2010) 0.94
Wireless capsule endoscopy in enteropathy induced by nonsteroidal anti-inflammatory drugs in pigs. Dig Dis Sci (2009) 0.91
Haemoglobin decreases in NSAID users over time: an analysis of two large outcome trials. Aliment Pharmacol Ther (2011) 0.90
GI-REASONS: a novel 6-month, prospective, randomized, open-label, blinded endpoint (PROBE) trial. Am J Gastroenterol (2013) 0.88
Lower gastrointestinal adverse effects of NSAIDS: an extreme example of a common problem. BMJ Case Rep (2013) 0.84
Comparison of gastrointestinal adverse effects between cyclooxygenase-2 inhibitors and non-selective, non-steroidal anti-inflammatory drugs plus proton pump inhibitors: a systematic review and meta-analysis. J Gastroenterol (2012) 0.83
Cyclo-oxygenase-2 inhibitors or nonselective NSAIDs plus gastroprotective agents: what to prescribe in daily clinical practice? Aliment Pharmacol Ther (2013) 0.82
Contrasting Pattern of Chronic Inflammatory Bowel Disease in Primary and Autoimmune Sclerosing Cholangitis. EBioMedicine (2015) 0.81
Role of enhanced visibility in evaluating polyposis syndromes using a newly developed contrast image capsule endoscope. Gut Liver (2012) 0.81
NSAID-Induced Enteropathy in Rheumatoid Arthritis Patients with Chronic Occult Gastrointestinal Bleeding: A Prospective Capsule Endoscopy Study. Gastroenterol Res Pract (2013) 0.80
Evaluation of small bowel blood flow in healthy subjects receiving low-dose aspirin. World J Gastroenterol (2011) 0.80
Activation of the farnesoid-X receptor protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs in mice. Br J Pharmacol (2011) 0.79
Patient-level pooled analysis of adjudicated gastrointestinal outcomes in celecoxib clinical trials: meta-analysis of 51,000 patients enrolled in 52 randomized trials. Arthritis Res Ther (2013) 0.78
Effect of long-term proton pump inhibitor therapy and healing effect of irsogladine on nonsteroidal anti-inflammatory drug-induced small-intestinal lesions in healthy volunteers. J Clin Biochem Nutr (2015) 0.78
Is a fecal occult blood test a useful tool for judging whether to perform capsule endoscopy in low-dose aspirin users with negative colonoscopy and esophagogastroduodenoscopy? J Gastroenterol (2016) 0.78
Small bowel injury induced by selective cyclooxygenase-2 inhibitors: a prospective, double-blind, randomized clinical trial comparing celecoxib and meloxicam. J Gastroenterol (2011) 0.77
Small intestinal injury in NSAID users suffering from rheumatoid arthritis or osteoarthritis. Rheumatol Int (2016) 0.77
Activation of the bile acid receptor GPBAR1 protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs and aspirin in mice. Br J Pharmacol (2013) 0.77
Double-contrast barium enteroclysis as a patency tool for nonsteroidal anti-inflammatory drug-induced enteropathy. Dig Dis Sci (2011) 0.76
Identifying and assessing benefit-risk in primary care--a family physician's perspective. Rheumatology (Oxford) (2010) 0.76
Small bowel injury in low-dose aspirin users. J Gastroenterol (2014) 0.76
Usefulness of virtual chromoendoscopy in the evaluation of subtle small bowel ulcerative lesions by endoscopists with no experience in videocapsule. Endosc Int Open (2016) 0.75
Mucosal healing effect of mesalazine granules in naproxen-induced small bowel enteropathy. World J Gastroenterol (2013) 0.75
Celecoxib and Diclofenac Plus Omeprazole are Similarly Effective in the Treatment of Arthritis in Patients at High GI Risk in the CONDOR Trial. Open Rheumatol J (2013) 0.75
CT enteroclysis/enterography findings in drug-induced small-bowel damage. Br J Radiol (2014) 0.75
Management of Musculoskeletal Manifestations in Inflammatory Bowel Disease. Gastroenterol Res Pract (2015) 0.75
Cyclooxygenase-2 inhibitors in patients with high gastrointestinal risk: are we there yet? J Gastroenterol (2009) 0.75
A Review of Anti-Inflammatory Drug-Induced Gastrointestinal Injury: Focus on Prevention of Small Intestinal Injury. Pharmaceuticals (Basel) (2010) 0.75
Small bowel ulcerative lesions are common in elderly NSAIDs users with peptic ulcer bleeding. World J Gastrointest Endosc (2014) 0.75
Clinical Review of Small-Bowel Endoscopic Imaging. Gastroenterol Hepatol (N Y) (2014) 0.75
Analgesic efficacy of celecoxib in patients after oral surgery: special reference to time to onset of analgesia and duration of analgesic effect. Oral Maxillofac Surg (2016) 0.75
Surveillance using capsule endoscopy is safe in post-colectomy patients with familial adenomatous polyposis: a prospective Japanese study. Fam Cancer (2016) 0.75
Frequency of risk factors for ischaemic heart-disease in a healthy British population. With particular reference to serum-lipoprotein levels. Lancet (1974) 8.19
Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS) Lancet (1992) 7.04
Blood lipid concentrations and other cardiovascular risk factors: distribution, prevalence, and detection in Britain. Br Med J (Clin Res Ed) (1988) 7.02
Strategies for reducing coronary heart disease and desirable limits for blood lipid concentrations: guidelines of the British Hyperlipidaemia Association. Br Med J (Clin Res Ed) (1987) 5.01
The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain. Gastroenterology (1998) 3.60
Structural relationships among Rhizobium meliloti symbiotic promoters. Cell (1983) 3.23
The value of lowering cholesterol after myocardial infarction. N Engl J Med (1990) 3.10
Interaction between transcription factors Sp1 and YY1. Nature (1993) 2.87
Cytogenetic analysis of a segment of the Y chromosome of Drosophila melanogaster. Genetics (1984) 2.75
Evaluation of the PillCam Colon capsule in the detection of colonic pathology: results of the first multicenter, prospective, comparative study. Endoscopy (2006) 2.42
The role of wireless capsule endoscopy in investigating unexplained iron deficiency anemia after negative endoscopic evaluation of the upper and lower gastrointestinal tract. Endoscopy (2006) 2.41
Cimetidine and HDL cholesterol. Lancet (1983) 2.40
Colonic neoplasia in patients with nonspecific GI symptoms. Gastrointest Endosc (2000) 2.39
Dietary fatty acids and progression of coronary artery disease in men. Am J Clin Nutr (1996) 2.26
Performance-based physician reimbursement and influenza immunization rates in the elderly. The Primary-Care Physicians of Monroe County. Am J Prev Med (1998) 2.23
Lipoprotein fractionation by a precipitation method. A simple quantitative procedure. Clin Chim Acta (1976) 2.19
Cardiac surgery in Wessex: review of 1000 consecutive open-heart procedures. Br Med J (1976) 2.16
Reducing the risks of coronary heart disease in individuals and in the population. Lancet (1986) 1.95
Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation. Am J Gastroenterol (1997) 1.91
Absorption of vitamin D3-3H in control subjects and patients with intestinal malabsorption. J Clin Invest (1966) 1.88
Plasma triglyceride and high density lipoprotein cholesterol as predictors of ischaemic heart disease in British men. The Caerphilly and Speedwell Collaborative Heart Disease Studies. Br Heart J (1992) 1.88
Acquired immune dysfunction in homosexual men: immunologic profiles. Clin Immunol Immunopathol (1983) 1.86
Family accommodation in obsessive-compulsive disorder. Am J Psychiatry (1995) 1.84
Conversion of very low density lipoprotein to low density lipoprotein. A metabolic study of apolipoprotein B kinetics in human subjects. J Clin Invest (1975) 1.82
Guidelines for credentialing and granting privileges for endoscopic ultrasound. Gastrointest Endosc (2001) 1.81
Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins. Br Med J (Clin Res Ed) (1981) 1.80
The modernization of Asia. Implications for coronary heart disease. Council on Arteriosclerosis of the International Society and Federation of Cardiology. Circulation (1996) 1.76
How effective are current drugs for Crohn's disease? A meta-analysis. J Clin Gastroenterol (1992) 1.75
Epidemic perinatal listeriosis. Pediatr Infect Dis (1984) 1.74
Towards an improved lipid-lowering diet: additive effects of changes in nutrient intake. Lancet (1981) 1.61
The cost-effectiveness of the omeprazole test in patients with noncardiac chest pain. Am J Med (1999) 1.60
Patterns of endoscopy use in the United States. Gastroenterology (2000) 1.59
Endoscopic treatment outcomes in watermelon stomach patients with and without portal hypertension. Endoscopy (2004) 1.57
Kinetic bases of the primary hyperlipidaemias: studies of apolipoprotein B turnover in genetically defined subjects. Eur J Clin Invest (1980) 1.55
Quality of life after treatment for pancreatitis. Ann Surg (1996) 1.53
Principles of privileging and credentialing for endoscopy and colonoscopy. Surg Endosc (2002) 1.52
The risk of esophageal cancer in patients with achalasia. A population-based study. JAMA (1995) 1.51
Serum bile acids in liver disease. Gut (1971) 1.50
Does level of sedation impact detection of advanced neoplasia? Dig Dis Sci (2010) 1.48
Distribution and characterization of canine Chagas disease in Texas. Vet Parasitol (2008) 1.48
A new system for defining endoscopic complications emphasizing the measure of importance. Gastrointest Endosc (1997) 1.48
Cancer procoagulant A: a factor X activating procoagulant from malignant tissue. Thromb Res (1975) 1.47
A pooled analysis to evaluate results of capsule endoscopy trials. Endoscopy (2005) 1.43
Distribution of vaccine/antivirals and the 'least spread line' in a stratified population. J R Soc Interface (2009) 1.42
Nonsteroidal antiinflammatory agents. I. 6-substituted 2-naphthylacetic acids. J Med Chem (1970) 1.38
Psychiatric training for family doctors: what do GP registrars want and can a brief course provide this? Med Educ (1999) 1.37
Differences in body composition of black and white girls. Am J Clin Nutr (1996) 1.36
Hapten-reactive inducer T cells. I. Definition of two classes of hapten-specific inducer cells. J Exp Med (1983) 1.33
Quantitative studies of very low density lipoprotein: conversion to low density lipoprotein in normal controls and primary hyperlipidaemic states and the role of direct secretion of low density lipoprotein in heterozygous familial hypercholesterolaemia. Eur J Clin Invest (1980) 1.32
Serum-bile-acids in the stagnant-loop syndrome. Lancet (1969) 1.30
Mutations in the steroidogenic acute regulatory protein (StAR) in six patients with congenital lipoid adrenal hyperplasia. J Clin Endocrinol Metab (2000) 1.29
Risk factors for cardiopulmonary events during propofol-mediated upper endoscopy and colonoscopy. Aliment Pharmacol Ther (2006) 1.29
Coronary heart disease: reducing the risk: the scientific background to primary and secondary prevention of coronary heart disease. A worldwide view. International Task force for the Prevention of Coronary Heart disease. Arterioscler Thromb Vasc Biol (1999) 1.26
Selective retention of VLDL, IDL, and LDL in the arterial intima of genetically hyperlipidemic rabbits in vivo. Molecular size as a determinant of fractional loss from the intima-inner media. Arterioscler Thromb Vasc Biol (1995) 1.25
A comparison of liver transplantation outcomes in the pre- vs. post-MELD eras. Aliment Pharmacol Ther (2005) 1.25
Accident and emergency: why patients choose A and E. Health Soc Serv J (1981) 1.25
Muscle strength as a predictor of bone mineral density in young women. J Bone Miner Res (1990) 1.24
Treatment of hyperlipidaemia retards progression of symptomatic femoral atherosclerosis. A randomised controlled trial. Lancet (1983) 1.24
How to develop and use a patient questionnaire. Physicians Manage (1986) 1.24
Differences in the management of Crohn's disease among experts and community providers, based on a national survey of sample case vignettes. Aliment Pharmacol Ther (2007) 1.23
p53 nuclear protein overexpression in colorectal cancer: a dominant predictor of survival in patients with advanced hepatic metastases. J Clin Oncol (1996) 1.20
Thyroid function in coronary-artery disease. Lancet (1971) 1.20
Studies in the metabolism of cholesterol in subjects with normal plasma cholesterol levels and in patients with essential hypercholesterolaemia. Clin Sci (1967) 1.20
Coronary artery reperfusion in acute myocardial infarction: beneficial effects of intracoronary streptokinase on left ventricular salvage and performance. Am Heart J (1981) 1.20
Prevalence of ischaemic heart disease and associations with serum lipoproteins in subjects aged 45 to 64 years. The Speedwell study. Br Heart J (1982) 1.19
Biliary sclerosis in patients receiving hepatic arterial infusions of floxuridine. J Clin Oncol (1985) 1.19
Serum lipids in cholelithiasis: effect of chenodeoxycholic acid therapy. Br Med J (1973) 1.17
Determination of individual bile acids in biological fluids by thin-layer chromatography and fluorimetry. J Clin Pathol (1970) 1.17
Quality of life measurement in gastroenterology: what is available? Am J Gastroenterol (2001) 1.17
A performance-based incentive program for influenza immunization in the elderly. Am J Prev Med (1993) 1.16
Serum lipoprotein abnormalities in patients with ischaemic heart disease: comparisons with a control population. Br Med J (1974) 1.16
The role of laparoscopy in the management of intussusception in the Peutz-Jeghers syndrome: case report and review of the literature. Surg Laparosc Endosc (1998) 1.16
Deaths in the first 10 minutes. Br Med J (Clin Res Ed) (1983) 1.15
Predicting the presence of choledocholithiasis in patients with symptomatic cholelithiasis. Am J Gastroenterol (1996) 1.15
Serum lipids and lipoproteins in peripheral vascular disease. Lancet (1971) 1.14
Familial apolipoprotein CII deficiency: plasma lipoproteins and apolipoproteins in heterozygous and homozygous subjects and the effects of plasma infusion. Eur J Clin Invest (1981) 1.14
Clinical and economic assessment of the omeprazole test in patients with symptoms suggestive of gastroesophageal reflux disease. Arch Intern Med (1999) 1.13
Effect of tamoxifen on oestrogen binding, lipid and lipoprotein concentrations and blood clotting parameters in premenopausal women with breast pain. J Endocrinol (1988) 1.12
Influence of dietary fat on platelet function in men. Lancet (1973) 1.11
Plasma triglyceride and fatty acid metabolism in diabetes mellitus. Eur J Clin Invest (1972) 1.11
Control of biodegradative threonine dehydratase inducibility by cyclic AMP in energy-restricted Escherichia coli. J Bacteriol (1978) 1.11
Induction of long-term specific tolerance to allografts in rats by therapy with an anti-CD3-like monoclonal antibody. Transplantation (1993) 1.11
Determination of the intravenous fat tolerance test with intralipid by nephelometry. Atherosclerosis (1972) 1.11
Hyperlipoproteinaemia in gout. Ann Rheum Dis (1971) 1.11
Association of isoapolipoprotein-E3 deficiency with heterozygous familial hypercholesterolaemia: implications for lipoprotein physiology. Lancet (1981) 1.11
Dietary prevention of ischaemic heart disease--a policy for the '80s. Br Med J (1980) 1.09
A pilot study of recombinant insulin-like growth factor-1 in seven multiple sderosis patients. Mult Scler (2002) 1.09
An alternative procedure for incorporating radiolabelled cholesteryl ester into human plasma lipoproteins in vitro. Biochem J (1985) 1.08
An overview of the oral health component of the 1988-1991 National Health and Nutrition Examination Survey (NHANES III-Phase 1). J Dent Res (1996) 1.08
Vitamin-D absorption after partial gastrectomy. Lancet (1966) 1.08
Cost of Alzheimer's disease and related dementia in managed-medicare. J Am Geriatr Soc (1999) 1.08
Influence of lipid concentrations and age on transfer of plasma lipoprotein into human arterial intima. Lancet (1977) 1.07
Electrogenic sodium absorption and chloride secretion by an inner medullary collecting duct cell line (mIMCD-K2). Am J Physiol (1995) 1.07
Disfluencies at the onset of stuttering. J Speech Hear Res (1984) 1.06
Crohn's disease: does race matter? The Mid-Atlantic Crohn's Disease Study Group. Am J Gastroenterol (2000) 1.06
A novel diagnostic tool for detecting oesophageal pathology: the PillCam oesophageal video capsule. Aliment Pharmacol Ther (2004) 1.06
Evaluation of the roles of lipoprotein lipase and hepatic lipase in lipoprotein metabolism: in vivo and in vitro studies in man. Eur J Clin Invest (1980) 1.06
Effective lipid lowering diets including lean meat. Br Med J (Clin Res Ed) (1988) 1.05
Coronary heart disease: reducing the risk: a worldwide view. International Task Force for the Prevention of Coronary Heart Disease. Circulation (1999) 1.05